Fig. 1From: Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancerInclusion and exclusion flow diagram. NSCLC, non-small cell cancer; ILD, interstitial lung disease; Bev, bevacizumab; CDDP, cisplatin; PEM, pemetrexed; CBDCA, carboplatin; PTX, paclitaxel; DTX, docetaxel; VNR, vinorelbineBack to article page